[Therapy of atopic eczema in the new light. When the skin barrier is not firm].
Kreutzkamp
Barbara
B
D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D003937:Diagnosis, Differential; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use; D005512:Food Hypersensitivity / Q000175:diagnosis; D006801:Humans; D009154:Mutation; D009824:Ointments; D010539:Permeability; D016032:Randomized Controlled Trials as Topic; D012879:Skin Physiological Phenomena; D013997:Time Factors
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents; D015525:Fatty Acids, Omega-3; D009824:Ointments; D004281:Docosahexaenoic Acids